Silphium Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Silphium Asset Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-225,779	Closed	-$9.76M	–	35
2015 Q3	$9.76M	Sell	225,779 -40,450	-15%	-$1.71M	2.14%	9
2015 Q2	$11.3M	Buy	+266,229	New	+$11.2M	1.98%	9

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Silphium Asset Management's WX Position: Q4 2015 in Review

Silphium Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 225,779 shares — an estimated $9.76M sold.

Silphium Asset Management first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $11.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Silphium Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Silphium Asset Management sold 225,779 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $9.76M.
Silphium Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
Silphium Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $11.3M in Q2 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Silphium Asset Management's 13F filing for Q4 2015, filed 30 Jan 2025.